Completed OBSERVATIONAL NCT00670943

Effect of Abrupt Plavix® Discontinuation on Platelet Function

Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

Updated 7 times since 2017 Last updated: Mar 24, 2009 Started: Jan 31, 2008 Primary completion: Mar 31, 2009 Completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00670943, this observational or N/A phase trial focuses on Coronary Artery Disease and remains completed. Sponsored by Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal, it has been updated 7 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Jul 2025 — Present [monthly]

Completed
Sep 2024 — Jul 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Université de Montréal

Data source: Université de Montréal

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada